Search

everythinglearnresearchcommunity

for

Search:↓

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

Oncoplastic breast surgery is more cost-effective than standard lumpectomy for large-breasted women despite being more expensive.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

The document listed medical job ads and guidelines for breast cancer screening.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

Oral minoxidil may help hair regrowth in female cancer survivors.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Curcuma aeruginosa rhizome extracts show potential as anticancer agents, with varying effectiveness against breast cancer cells.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Certain skin diseases are linked to Agent Orange and similar chemicals; veterans should be screened and informed about uncertain risks, and current data doesn't link spironolactone with breast cancer.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

Hair loss is a common side effect of hormone treatments for cancer.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.